Article Versions Notes

Han R, Zhou H, Peng B, Yu S, Zhu J, Chen J. Synergistic Integration of HDAC Inhibitors and Individualized Neoantigen Therapy (INT): A Next-Generation Combinatorial Approach for Cancer Immunotherapy. Vaccines. 2025; 13(6):550. https://doi.org/10.3390/vaccines13060550

Han, Rui, Huiling Zhou, Baoqing Peng, Shasha Yu, Jiajie Zhu, and Jiaojiao Chen. 2025. "Synergistic Integration of HDAC Inhibitors and Individualized Neoantigen Therapy (INT): A Next-Generation Combinatorial Approach for Cancer Immunotherapy" Vaccines 13, no. 6: 550. https://doi.org/10.3390/vaccines13060550

Han, R., Zhou, H., Peng, B., Yu, S., Zhu, J., & Chen, J. (2025). Synergistic Integration of HDAC Inhibitors and Individualized Neoantigen Therapy (INT): A Next-Generation Combinatorial Approach for Cancer Immunotherapy. Vaccines, 13(6), 550. https://doi.org/10.3390/vaccines13060550